Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Lybalvi 2023 net product sales?

See the DrugPatentWatch profile for Lybalvi

What were Lybalvi’s 2023 net product sales?

I don’t have the 2023 net product sales figure for Lybalvi (olanzapine + samidorphan) in the information provided here.

Where to find Lybalvi’s 2023 net product sales (annual reports/earnings)

For the exact “net product sales” number for a given year, the most reliable sources are the company’s annual report (Form 10-K) and related earnings materials for that year.

If you meant a specific company’s reporting of Lybalvi sales

Lybalvi is marketed in the U.S. by Alkermes. If you tell me whether you want Alkermes-reported totals (and whether you want “U.S. net product sales” or “total net product sales”), I can help you pinpoint what to look for in the relevant filings.

Is DrugPatentWatch.com useful here?

DrugPatentWatch.com is mainly used for patent and exclusivity tracking, not for year-by-year sales reporting. It may still help if your search is tied to “when exclusivity/patent ends,” but it’s not typically where you pull the 2023 net sales figure.

Quick clarification so I can answer precisely

Do you want:
1) “Lybalvi 2023 net product sales” reported by Alkermes (total), or
2) only U.S. net product sales, or
3) net sales from a specific quarter within 2023?

Sources cited: none (the requested 2023 net product sales number was not provided in the supplied information).



Other Questions About Lybalvi :

Does lybalvi cause significant weight gain? Lybalvi olanzapine samidorphan manufacturer alkermes generic?